Unilex Lifesciences Private Limited, a active private limited company, was established on 06 September 2011 in Panampilly Nagar, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233KL2011PTC029307. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 41 professional, Its leadership includes Vimalkumar Viswanathan (Director), Suraj Premraj (Director), Rajesh Kumar Rajan (Managing Director). Past directors included Vimalkumar Viswanathan, Jyothish Kanth Sukumaran, Muhammedlabba Chempakasseril Faisal Mussaliyar. It holds ₹2.14 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 38/455 (New No. 63/2503, Anjiparambil Building, Ground Floor, Near Manorama Junction ,, Panampilly Nagar, Kerala, 682016.
U24233KL2011PTC029307
029307
06 September 2011
₹0.10 M
₹0.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Unilex Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vimalkumar Viswanathan | Director | 14 Jun 2013 | Current |
| Suraj Premraj | Director | 28 Aug 2019 | Current |
| Rajesh Kumar Rajan | Managing Director | 10 Aug 2012 | Current |
| Narendrakurup Sarasamma Gopakumar | Director | 25 Jul 2016 | Current |
| Hashim Kaithakalathil | Director | 06 Sep 2011 | Current |
| Rajesh Radha Krishnan | Director | 22 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2013 | Past |
| Pramod Abcsdd | Director | 12 Sep 2015 | Past |
| Pramod Abcsdd | Director | 14 Feb 2018 | Past |
| Pramod Abcsdd | Managing Director | 14 Feb 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unilex Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.75% increase. The company also saw a substantial improvement in profitability, with a 51.44% increase in profit. The company's net worth Soared by an impressive increase of 37.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Unilex Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹21,418,923.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2025 | Hdfc Bank Limited | ₹3.04 M | Open |
| 14 May 2025 | Hdfc Bank Limited | ₹3.63 M | Open |
| 31 Jan 2025 | Hdfc Bank Limited | ₹2.14 M | Open |
| 17 Jul 2024 | Hdfc Bank Limited | ₹0.82 M | Open |
| 11 Dec 2023 | Hdfc Bank Limited | ₹0.83 M | Open |
Explore comprehensive loan charge details -
Unilex Lifesciences has a workforce of 41 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Unilex Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unilex Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.04 M with Charge ID 101147277 was registered on 23 Jul 2025. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.63 M with Charge ID 101099317 was registered on 14 May 2025. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.14 M with Charge ID 101041853 was registered on 31 Jan 2025. was documented.
Progress on Unilex Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.82 M with Charge ID 100949748 was registered on 17 Jul 2024. was documented.
Progress on Unilex Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The CIN of Unilex Lifesciences Private Limited is U24233KL2011PTC029307.
Unilex Lifesciences Private Limited is headquartered at 38/455 (New No. 63/2503, Anjiparambil Building, Ground Floor, Near Manorama Junction ,, Panampilly Nagar, Kerala, 682016.
Unilex Lifesciences Private Limited was incorporated on 06 September 2011.
The current directors of Unilex Lifesciences Private Limited are
The primary industry of Unilex Lifesciences Private Limited is Trade.
Unilex Lifesciences Private Limited is unlisted.
The authorized capital of Unilex Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Unilex Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX